MBX Biosciences, Inc. (MBX) vs Precigen, Inc. (PGEN)
MBX Biosciences, Inc. and Precigen, Inc. are both Biotechnology companies. MBX Biosciences, Inc. and Precigen, Inc. are of similar size ($2.8B and $2.7B). MBX Biosciences, Inc. has the higher net margin (0.00% vs −392.8%) and the higher return on invested capital (0.00% vs −24.9%). Across the 13 metrics below, MBX Biosciences, Inc. leads on 12 and Precigen, Inc. on 1.
Valuation
Profitability
| Metric | MBX | PGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 90.67% | 65.16% |
| Operating margin | 0.00% | (46.08%) | 0.00% |
| Net margin | 0.00% | (392.81%) | 0.00% |
| Free cash flow margin | 0.00% | (134.42%) | 0.00% |
| Return on equity | (33.17%) | (9,907.46%) | (57.72%) |
| Return on assets | (31.25%) | (247.40%) | (49.22%) |
| Return on invested capital | 0.00% | (24.87%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack